Oxford Biomedica extends deal with AstraZeneca to make Covid vaccines on an as-needed basis
Oxford Biomedica have inked a new three-year agreement to make AstraZeneca's COVID-19 vaccine beyond 2022.
Full Article
Oxford Biomedica extends deal with AstraZeneca to make Covid vaccines on an as-needed basis
City A.M.
0 shares
1 views
You might like
Related news coverage
Oxford BioMedica extends Covid vaccine deal with AstraZeneca
New three-year contract in place if UK drugmaker continues to manufacture the jab
FT.com